Mariner’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$367K Buy
17,839
+2,484
+16% +$56K ﹤0.01% 2703
2025
Q4
$365K Sell
15,355
-1,796
-10% -$43.7K ﹤0.01% 2686
2025
Q3
$427K Sell
17,151
-19,537
-53% -$420K ﹤0.01% 2557
2025
Q2
$844K Sell
36,688
-25,879
-41% -$599K ﹤0.01% 1929
2025
Q1
$1.4M Sell
62,567
-19,289
-24% -$448K ﹤0.01% 1448
2024
Q4
$1.6M Sell
81,856
-25,062
-23% -$497K ﹤0.01% 1346
2024
Q3
$1.95M Buy
106,918
+3,262
+3% +$62.2K ﹤0.01% 1202
2024
Q2
$1.8M Sell
103,656
-1,391
-1% -$24.6K ﹤0.01% 1164
2024
Q1
$2.06M Buy
105,047
+95,082
+954% +$2.01M ﹤0.01% 1096
2023
Q4
$229K Buy
9,965
+418
+4% +$9.36K ﹤0.01% 2579
2023
Q3
$220K Buy
9,547
+868
+10% +$22.1K ﹤0.01% 2428
2023
Q2
$227K Buy
+8,679
New +$229K ﹤0.01% 2359
2022
Q4
Sell
-6,055
Closed -$206K 2818
2022
Q3
$206K Buy
+6,055
New +$224K ﹤0.01% 2041

Other funds holding PRVA

Mariner's PRVA Position: Q1 2026 in Review

Mariner increased its Privia Health (PRVA) stake by 16% in Q1 2026, buying an estimated $56K and bringing the position to 17,839 shares worth $367K. The position accounts for ﹤0.01% of the portfolio, ranked #2703.

Mariner first reported a position in PRVA in Q3 2022 and has held it in 13 quarters since. The position peaked at $2.06M in Q1 2024. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • Mariner held 17,839 shares of Privia Health worth $367K as of Q1 2026.
  • Mariner bought 2,484 Privia Health shares in Q1 2026, an estimated $56K.
  • Privia Health made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #2703 holding.
  • Mariner first reported a position in Privia Health in Q3 2022 and has held it in 13 quarters since.
  • Mariner's Privia Health position peaked at $2.06M in Q1 2024.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.